Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met inhibitors for the treatment of NSCLC-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met inhibitors for the treatment of NSCLC

Published:2024-01 Issue: Volume:263 Page:115939
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Tang Sheng,Sun Chuanchuan,He Xintao,Gan Wenhui,Wang Linxiao,Qiao Dan,Guan Xinyu,Xu Shan,Zheng Pengwu,Zhu Wufu^ORCID

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference36 articles.

1. Improving diagnosis accuracy of non-small cell lung carcinoma on noisy data by adaptive group lasso regularized multinomial regression;Li;Biomed. Signal Process Control,2023

2. Targeted therapies for treatment of non-small cell lung cancer—recent advances and future perspectives;Minguet;Int. J. Cancer,2016

3. Comparison of adverse events of erlotinib with those of gefitinib in patients with non-small cell lung cancer: a case-control study in a Japanese population;Suzumura;Osaka City Med. J.,2012

4. Pre-clinical drug-drug interaction (DDI) of gefitinib or erlotinib with Cytochrome P450(CYP) inhibiting drugs, fluoxetine and/or losartan;Luong;Curr. Res. Toxicol.,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP